|
Re: Nasdaq listing requirements - Another reason for this raise?
|
3
|
Resverlogix Corp.
|
May 30, 2019 08:25AM
|
|
Re: New Apabetalone Publication in Clinical Epigenetics
|
3
|
Resverlogix Corp.
|
Jul 12, 2019 05:58PM
|
|
Re: eGFR data question from IR
|
3
|
Resverlogix Corp.
|
Nov 26, 2019 04:57PM
|
|
Re: No love
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 12:39PM
|
|
Any way to find out what was said at CTAD...
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 03:09PM
|
|
Re: Dots that don’t connect
|
3
|
Resverlogix Corp.
|
Feb 16, 2019 11:43AM
|
|
Re: No love
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 12:59PM
|
|
Price moving up nicely today
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 02:27PM
|
|
Re: Useful review on epigenetics and CKD for the scientists
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 09:38AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
3
|
Resverlogix Corp.
|
Dec 02, 2019 10:50AM
|
|
Re: I'm anxiously awaiting the next short interest update...
|
3
|
Resverlogix Corp.
|
Jun 10, 2019 12:42PM
|
|
Re: What value will be given Apabetalone for CD,...
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 09:50AM
|
|
I would rather,...
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 03:40PM
|
|
Re: Next private placement/licensing agreement
|
3
|
Resverlogix Corp.
|
Feb 07, 2019 09:14AM
|
|
Up on good volume
|
3
|
Resverlogix Corp.
|
Feb 28, 2020 02:08PM
|
|
Are statins overprescribed? Why the risks and benefits are so complex
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 10:17AM
|
|
Re: Holding steady
|
3
|
Resverlogix Corp.
|
Dec 22, 2018 02:44PM
|
|
What i don't understand,...
|
3
|
Resverlogix Corp.
|
Nov 19, 2019 08:53AM
|
|
Re: 5 million shares
|
3
|
Resverlogix Corp.
|
Sep 27, 2019 10:45AM
|
|
Re: 4-8b guess - Is someone asking too much?
|
3
|
Resverlogix Corp.
|
Dec 09, 2019 10:37AM
|
